Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Polpharma Appoints CEO

This article was originally published in Scrip

Executive Summary

Poland based leading generics player, Polpharma, has appointed Dr. Maurice Chagnaud as CEO. Chagnaud joins Polpharma with over 20 years' experience in generics, OTC medicines and biosimilars. For 12 years he was responsible for Merck Generics' commercial operations in France and was also general manager of Merck Generics Italia. He has held various positions at TEVA, where he was general manager of TEVA and Iva France, chief commercial officer of TEVA Europe and senior vice-president in Central and Eastern Europe. Recently he was President Europe- Russia and CIS and global head of inhalation strategy at Lupin.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts